MEAGAN ADAMSICK, PHARMD*

Articles by MEAGAN ADAMSICK, PHARMD*

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy

ByMEAGAN ADAMSICK, PHARMD*

December 20th 2020

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

ByMEAGAN ADAMSICK, PHARMD*,MONIQUE R. BIDELL, PHARMD, BCPS

February 11th 2020

Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.

Latest Updated Articles

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy
December 20th 2020
The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions
February 11th 2020

MEAGAN ADAMSICK, PHARMD*

Articles by MEAGAN ADAMSICK, PHARMD*

Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy

The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions

Latest Updated Articles

Trending on Contagion Live

Two Outbreaks Reveal a Dangerous Double Standard in Global Health

From Deadly Disease to Chronic Condition: How the Evolution of HIV Treatment Has Allowed People to Live Longer, Better Lives

FDA Accepts Shionogi's sNDA to Expand Cefiderocol Use to Pediatric Patients With Drug-Resistant Gram-Negative Infections

CDC, FDA Investigate Multistate Cyclospora Outbreak Linked to Taco Bell Shredded Lettuce

Cyclosporiasis: When to Seek Medical Care, Duration of Illness, and Preventive Measures